Revenue More Than Doubled Year‑Over‑Year
Total revenue grew to $1.038 billion in Q1 2026, an increase of ~105% YoY (≈+$506M). The Bowers acquisition contributed just over $240M; excluding Bowers, revenues rose ~57% YoY, driven primarily by Installation & Maintenance and data center/technology end markets.
Strong Adjusted EBITDA Growth and Margin Expansion
Adjusted EBITDA increased 132% YoY to $118M in Q1 2026. Adjusted EBITDA margin expanded by ~133 basis points to 11.4% versus the prior-year quarter.
Record Backlog and Healthy Book‑to‑Bill
Consolidated backlog and awards reached a record $5.4B, up 104% YoY; excluding Bowers backlog grew ~36% YoY. Book‑to‑bill for the quarter was 1.2x, and pro‑forma sequential adds were ≈$200M of net new backlog.
Raised Full‑Year Guidance
Management raised FY2026 revenue guidance to $4.1B–$4.3B (≈+10% vs prior guide of $3.7B–$3.9B) and increased full‑year adjusted EBITDA guidance to $470M–$490M (up from $400M–$430M).
Strong Free Cash Flow and High Conversion
Free cash flow exceeded $100M in Q1 2026, representing a conversion rate of >85% of adjusted EBITDA (vs ~50% conversion and ~$25M FCF in the year‑ago quarter), driven by improved working capital, operating performance and lower interest burden.
Deleveraging and Liquidity Position
Pro forma net leverage improved to ~1.8x (including Bowers) versus 2.9x nine months earlier. Cash was $245M and total liquidity ~$414M at quarter end, positioning the company with flexibility for disciplined M&A.
Fabrication & Modular Capacity Expansion
Approximately 1.3M sq. ft. of fabrication capacity largely operational; fabrication’s share of I&M revenue increased from ~20% toward the low‑20s. Management noted fabrication/modular work is accretive and driving demand from data center, pharma and semiconductor clients.
Workforce Growth to Support Demand
Headcount crossed 10,000 full‑time employees in April, including ~7.4k skilled technicians (up >1k since the start of the year) and 1.2k+ engineers/consultants, reducing near‑term labor constraint risk.